The Shank3

ASD model Shank3 Shank3a Shank3Δ⁢C isoform-specific tagging knock in

Journal

Frontiers in neuroscience
ISSN: 1662-4548
Titre abrégé: Front Neurosci
Pays: Switzerland
ID NLM: 101478481

Informations de publication

Date de publication:
2022
Historique:
received: 26 10 2022
accepted: 23 11 2022
entrez: 26 12 2022
pubmed: 27 12 2022
medline: 27 12 2022
Statut: epublish

Résumé

Shank3 is a scaffolding protein essential for the organization and function of the glutamatergic postsynapse. Monogenic mutations in In this study, we created a novel transgenic mouse line, the Shank3 We show that the endogenous Venus-Shank3a protein is localized in spines and is mainly expressed in the striatum, hippocampus and cortex of the developing and adult brain. We show that Shank3 Altogether, our results show that the Shank3

Sections du résumé

Background UNASSIGNED
Shank3 is a scaffolding protein essential for the organization and function of the glutamatergic postsynapse. Monogenic mutations in
Methods UNASSIGNED
In this study, we created a novel transgenic mouse line, the Shank3
Results UNASSIGNED
We show that the endogenous Venus-Shank3a protein is localized in spines and is mainly expressed in the striatum, hippocampus and cortex of the developing and adult brain. We show that Shank3
Conclusion UNASSIGNED
Altogether, our results show that the Shank3

Identifiants

pubmed: 36570823
doi: 10.3389/fnins.2022.1081010
pmc: PMC9773256
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1081010

Informations de copyright

Copyright © 2022 Bouquier, Sakkaki, Raynaud, Hemonnot-Girard, Seube, Compan, Bertaso, Perroy and Moutin.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Neurochem. 2002 Jun;81(5):903-10
pubmed: 12065602
Front Synaptic Neurosci. 2020 Apr 30;12:19
pubmed: 32425766
J Biol Chem. 1999 Oct 8;274(41):29510-8
pubmed: 10506216
J Neurosci. 2005 Apr 6;25(14):3560-70
pubmed: 15814786
Mol Autism. 2014 Apr 25;5:30
pubmed: 25071925
Dev Neurobiol. 2014 Feb;74(2):85-112
pubmed: 24218108
Mol Autism. 2018 Sep 15;9:48
pubmed: 30237867
Neuron. 2013 Apr 10;78(1):8-27
pubmed: 23583105
Cell Rep. 2015 Jun 9;11(9):1400-1413
pubmed: 26027926
Philos Trans R Soc Lond B Biol Sci. 2013 Dec 02;369(1633):20130143
pubmed: 24298145
J Neurosci. 2013 Nov 20;33(47):18448-68
pubmed: 24259569
Nat Rev Neurosci. 2015 Sep;16(9):551-63
pubmed: 26289574
Eur J Neurosci. 2016 Jan;43(2):179-93
pubmed: 26547831
Nat Genet. 2007 Jan;39(1):25-7
pubmed: 17173049
Neurotherapeutics. 2015 Jul;12(3):620-30
pubmed: 25894671
J Neurosci. 2019 Jul 3;39(27):5299-5310
pubmed: 31061091
Mol Psychiatry. 2012 Jan;17(1):71-84
pubmed: 21606927
Mol Psychiatry. 2021 Nov;26(11):6505
pubmed: 34234282
Neural Plast. 2016;2016:8051861
pubmed: 27795858
Am J Hum Genet. 2001 Aug;69(2):261-8
pubmed: 11431708
PLoS Genet. 2014 Sep 04;10(9):e1004580
pubmed: 25188300
Am J Med Genet. 2001 Jun 15;101(2):91-9
pubmed: 11391650
J Biol Chem. 2011 Oct 7;286(40):34839-50
pubmed: 21795692
Orphanet J Rare Dis. 2008 May 27;3:14
pubmed: 18505557
Nat Rev Neurosci. 2017 Mar;18(3):147-157
pubmed: 28179641
J Neurochem. 2015 Dec;135(5):849-58
pubmed: 26338675
Eur J Neurosci. 2014 Apr;39(7):1114-29
pubmed: 24712991
Mol Syndromol. 2012 Apr;2(3-5):186-201
pubmed: 22670140
Biol Psychiatry. 2017 May 15;81(10):838-847
pubmed: 27450033
Nature. 2016 Feb 25;530(7591):481-4
pubmed: 26886798
Acta Neuropathol. 2017 Oct;134(4):537-566
pubmed: 28584888
J Physiol. 2018 Apr 1;596(7):1123
pubmed: 29427308
Mol Autism. 2013 Jun 11;4(1):17
pubmed: 23758743
Neuron. 1999 Jul;23(3):583-92
pubmed: 10433269
Neuron. 1999 Jul;23(3):569-82
pubmed: 10433268
Psychopharmacology (Berl). 2014 Mar;231(6):1037-62
pubmed: 24419271
Mol Psychiatry. 2021 Dec;26(12):7596-7609
pubmed: 34331007
Neuron. 2001 Jul 19;31(1):115-30
pubmed: 11498055
Elife. 2022 Apr 26;11:
pubmed: 35471151
Nature. 2013 Nov 7;503(7474):72-7
pubmed: 24153177
Front Cell Neurosci. 2015 Mar 19;9:94
pubmed: 25852484

Auteurs

Nathalie Bouquier (N)

Institut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM, Montpellier, France.

Sophie Sakkaki (S)

Institut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM, Montpellier, France.

Fabrice Raynaud (F)

Institut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM, Montpellier, France.
PhyMedExp, Univ Montpellier, INSERM, CNRS, CHU de Montpellier, Montpellier, France.

Anne-Laure Hemonnot-Girard (AL)

Institut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM, Montpellier, France.

Vincent Seube (V)

Institut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM, Montpellier, France.

Vincent Compan (V)

Institut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM, Montpellier, France.

Federica Bertaso (F)

Institut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM, Montpellier, France.

Julie Perroy (J)

Institut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM, Montpellier, France.

Enora Moutin (E)

Institut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM, Montpellier, France.

Classifications MeSH